Advertisement

Biochemistry (Moscow)

, Volume 75, Issue 7, pp 905–911 | Cite as

Effect of human cell malignancy on activity of DNA polymerase ι

  • A. A. Kazakov
  • E. E. Grishina
  • V. Z. TarantulEmail author
  • L. V. Gening
Article

Abstract

An increased level of mutagenesis, partially caused by imbalanced activities of error prone DNA polymerases, is a key symptom of cell malignancy. To clarify the possible role of incorrect DNA polymerase ι (Pol ι) function in increased frequency of mutations in mammalian cells, the activity of this enzyme in extracts of cells of different mouse organs and human eye (melanoma) and eyelid (basal-cell skin carcinoma) tumor cells was studied. Both Mg2+, considered as the main activator of the enzyme reaction of in vivo DNA replication, and Mn2+, that activates homogeneous Pol ι preparations in experiments in vitro more efficiently compared to all other bivalent cations, were used as cofactors of the DNA polymerase reaction in these experiments. In the presence of Mg2+, the enzyme was active only in cell extracts of mouse testicles and brain, whereas in the presence of Mn2+ the activity of Pol ι was found in all studied normal mouse organs. It was found that in cell extracts of both types of malignant tumors (basal-cell carcinoma and melanoma) Pol ι activity was observed in the presence of either Mn2+ or Mg2+. Manganese ions activated Pol ι in both cases, though to a different extent. In the presence of Mn2+ the Pol ι activity in the basal-cell carcinoma exceeded 2.5-fold that in control cells (benign tumors from the same eyelid region). In extracts of melanoma cells in the presence of either cation, the level of the enzyme activity was approximately equal to that in extracts of cells of surrounding tumor-free tissues as well as in eyes removed after traumas. The distinctive feature of tissue malignancy (in basal-cell carcinoma and in melanoma) was the change in DNA synthesis revealed as Mn2+-activated continuation of DNA synthesis after incorrect incorporation of dG opposite dT in the template by Pol ι. Among cell extracts of different normal mouse organs, only those of testicles exhibited a similar feature. This similarity can be explained by cell division blocking that occurs in all normal cells except in testicles and in malignant cells.

Key words

uveal eye melanoma basal-cell carcinoma DNA polymerase ι TLS 

Abbreviations

BCC

basal-cell carcinoma

DTT

dithiothreitol

PNK

polynucleotide kinase

Pol ι

DNA polymerase ι

TLS

translesion synthesis

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rattray, A. J., and Strathern, J. N. (2003) Annu Rev. Genet., 37, 31–66.CrossRefPubMedGoogle Scholar
  2. 2.
    Zhang, Y., Yuan, F., Wu, X., and Wang, Z. (2000) Mol. Cell Biol., 20, 7099–7108.CrossRefPubMedGoogle Scholar
  3. 3.
    Gening, L. V., Makarova, A. V., Malashenko, A. M., and Tarantul, V. Z. (2006) Biochemistry (Moscow), 71, 155–159.CrossRefGoogle Scholar
  4. 4.
    Gening, L. V., Petrochenkov, A. N., Reshetnyak, A. B., Andreeva, L. E., and Tarantul, V. Z. (2004) Biochemistry (Moscow), 69, 435–440.CrossRefGoogle Scholar
  5. 5.
    Kazakov, A. A., Gening, L. V., Grishina, E. E., Petrochenkov, A. N., and Tarantul, V. Z. (2008) Med. Genet. (Moscow), 9, 27–31.Google Scholar
  6. 6.
    Dominguez, O., Ruiz, J. F., Lain de Lera, T., Garcia-Diaz, M., Gonzalez, M. A., Kirchhoff, T., Martinez, A. C., Bernad, A., and Blanco, L. (2000) EMBO J., 19, 1731–1742.CrossRefPubMedGoogle Scholar
  7. 7.
    Blanca, G., Shevelev, I., Ramadan, K., Villani, G., Spadari, S., Hubscher, U., and Maga, G. (2003) Biochemistry, 42, 7467–7476.CrossRefPubMedGoogle Scholar
  8. 8.
    Batra, V. K., Beard, W. A., Shock, D. D., Pedersen, L. C., and Wilson, S. H. (2008) Mol. Cell., 30, 315–324.CrossRefPubMedGoogle Scholar
  9. 9.
    McDonald, J. P., Frank, E. G., Plosky, B. S., Rogozin, I. B., Masutani, C., Hanaoka, F., Woodgate, R., and Gearhart, P. J. (2003) J. Exp. Med., 198, 635–643.CrossRefPubMedGoogle Scholar
  10. 10.
    Frank, E. G., and Woodgate, R. (2007) J. Biol. Chem., 282, 24689–24696.CrossRefPubMedGoogle Scholar
  11. 11.
    Acharya, N., Johnson, R. E., Prakash, S., and Prakash, L. (2006) Mol. Cell. Biol., 26, 9555–9563.CrossRefPubMedGoogle Scholar
  12. 12.
    Livneh, Z. (2006) Cell Cycle, 5, 1918–1922.PubMedGoogle Scholar
  13. 13.
    Bi, X., Barkley, L. R., Slater, D. M., Tateishi, S., Yamaizumi, M., Ohmori, H., and Vaziri, C. (2006) Mol. Cell Biol., 26, 3527–3540.CrossRefPubMedGoogle Scholar
  14. 14.
    Avkin, S., Sevilya, Z., Toube, L., Geacintov, N., Chaney, S. G., Oren, M., and Livneh, Z. (2006) Mol. Cell., 22, 407–413.CrossRefPubMedGoogle Scholar
  15. 15.
    Soria, G., Podhajcer, O., Prives, C., and Gottifredi, V. (2006) Oncogene, 25, 2829–2838.CrossRefPubMedGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2010

Authors and Affiliations

  • A. A. Kazakov
    • 1
  • E. E. Grishina
    • 2
  • V. Z. Tarantul
    • 1
    Email author
  • L. V. Gening
    • 1
  1. 1.Institute of Molecular GeneticsRussian Academy of SciencesMoscowRussia
  2. 2.Moscow Department of HealthOphthalmological Clinical HospitalMoscowRussia

Personalised recommendations